Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: Implication in IBD

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 6, 2010, Pages

  Ferrier, Laurent ^a   Gal, Claudine Serradeil Le ^b   Schulte, Anke M ^c   Vasina, Valentina ^d   Gaultier, Eric ^a   Schroedel, Silke ^c,e   Ursino, Maria Grazia ^d   Chaumaz, Gilles ^a   Pascal, Marc ^b   De Ponti, Fabrizio ^d   Bueno, Lionel ^a  

^a CNRS   (France)

^b SANOFI   (France)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e SIRION BIOTECH GMBH   (Germany)

Author keywords

Epithelial barrier; Inflammatory bowel disease

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN; VASOPRESSIN V1B RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; COLITIS; COLON; COLON MUCOSA; CONTROLLED STUDY; DEHYDRATION; DISEASE SEVERITY; FEMALE; GANGLION; HUMAN; HUMAN TISSUE; INTESTINE CELL; INTESTINE INNERVATION; MALE; MAST CELL; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SCORING SYSTEM; TISSUE LEVEL; WILD TYPE;

ANIMALS; COLITIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HAPTENS; HUMANS; INDOLES; INFLAMMATORY BOWEL DISEASES; MICE; PHOSPHODIESTERASE INHIBITORS; PYRROLIDINES; RATS; RECEPTORS, VASOPRESSIN; THIOXANTHENES; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA; VASOPRESSINS; WATER DEPRIVATION; WEIGHT GAIN; XANTHONES;

EID: 78649745785     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00022.2010     Document Type: Article

References (48)

1. Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 57: 582-590, 2008.
2. 125I]arginine vasopressin binding sites on human peripheral blood mononuclear cells. Life Sci 52: 95-105, 1993.
3. Boyd JH, Holmes CL, Wang Y, Roberts H, Walley KR. Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. Resuscitation 79: 325-331, 2008.
4. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
5. Bridges RJ, Nell G, Rummel W. Influence of vasopressin and calcium on electrolyte transport across isolated colonic mucosa of the rat. J Physiol 338: 463-475, 1983.
6. Bueno L, Gue M, Delrio C. CNS vasopressin mediates emotional stress and CRH-induced colonic motor alterations in rats. Am J Physiol Gastrointest Liver Physiol 262: G427-G431, 1992.
7. 2+ spiking activity in A7r5 vascular smooth muscle cells via activation of phospholipase A2. Circ Res 78: 813-820, 1996.
8. Chassin C, Hornef MW, Bens M, Lotz M, Goujon JM, Vimont S, Arlet G, Hertig A, Rondeau E, Vandewalle A. Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J Exp Med 204: 2837-2852, 2007.
9. Cristia E, Amat C, Naftalin RJ, Moreto M. Role of vasopressin in rat distal colon function. J Physiol 578: 413-424, 2007.
10. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371: 1624-1632, 2008.
11. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994.
12. Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 55: 655-661, 2006.
13. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643-1652, 1994.
14. Fabia R, Ar'Rajab A, Johansson ML, Willen R, Andersson R, Molin G, Bengmark S. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 28: 155-162, 1993.
15. Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 125: 795-804, 2003.
16. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21: 177-196, 2005.
17. Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, Ahrens R, Seidu L, McKenzie A, Strait R, Finkelman FD, Foster PS, Matthaei KI, Rothenberg ME, Hogan SP. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 205: 897-913, 2008.
18. Friedmann AS, Memoli VA, North WG. Evidence for vasopressin production in the human gastrointestinal system. Peptides 12: 1051-1056, 1991.
19. Gallardo P, Cid LP, Vio CP, Sepulveda FV. Aquaporin-2, a regulated water channel, is expressed in apical membranes of rat distal colon epithelium. Am J Physiol Gastrointest Liver Physiol 281: G856-G863, 2001.
20. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermuller N, Otto HF, Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 281: G216-G228, 2001.
21. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, Macias MA, Rendon P, Diaz F, Fernandez-Gutierrez C, Martin-Herrera L. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 24: 437-445, 2004.
22. Grotjohann I, Schmitz H, Fromm M, Schulzke JD. Effect of TNF alpha and IFN gamma on epithelial barrier function in rat rectum in vitro. Ann NY Acad Sci 915: 282-286, 2000.
23. Han DM, Zhang YQ, Bai QX, Chen XQ. Assay of AVP, CRP, and LPS in leukemia. Int J Lab Hematol 29: 185-189, 2007.
24. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30: 171-177, 1986.
25. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299: 442-448, 2001.
26. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159: 2001-2009, 2001.
27. Levitan R, Mauer I. Effect of intravenous antidiuretic hormone administration on salt and water absorption from the human colon. J Lab Clin Med 72: 739-746, 1968.
28. Maybauer MO, Maybauer DM, Enkhbaatar P, Traber DL. Physiology of the vasopressin receptors. Best Pract Res Clin Anaesthesiol 22: 253-263, 2008.
29. Mishima K, Tsukikawa H, Inada K, Fujii M, Iwasaki K, Matsumoto Y, Abe K, Egawa T, Fujiwara M. Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. Eur J Pharmacol 427: 43-52, 2001.
30. Monstein HJ, Truedsson M, Ryberg A, Ohlsson B. Vasopressin receptor mRNA expression in the human gastrointestinal tract. Eur Surg Res 40: 34-40, 2008.
31. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
32. Orcel H, Albizu L, Perkovska S, Durroux T, Mendre C, Ansanay H, Mouillac B, Rabie A. Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane. Mol Pharmacol 75: 637-647, 2009.
33. Patchev VK, Mastorakos G, Brady LS, Redwine J, Wilder RL, Chrousos GP. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 58: 106-110, 1993.
34. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104: 802-809, 1993.
35. Saito M, Sugimoto T, Tahara A, Kawashima H. Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 212: 751-757, 1995.
36. Santos J, Alonso C, Vicario M, Ramos L, Lobo B, Malagelada JR. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome. Curr Mol Med 8: 258-273, 2008.
37. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrie P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, and Le Fur G. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4- dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl] -4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther 300: 1122-1130, 2002.
38. Subburaju S, Aguilera G. Vasopressin mediates mitogenic responses to adrenalectomy in the rat anterior pituitary. Endocrinology 148: 3102-3110, 2007.
39. Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovasc Res 38: 198-205, 1998.
40. Torres BA, Johnson HM. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes. J Immunol 140: 2179-2183, 1988.
41. Ursino MG, Vasina V, De Ponti F. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats. Eur J Pharmacol 603: 133-137, 2009.
42. Varga C, Pavo I, Lamarque D, Szepes Z, Kiss J, Karacsony G, Laszlo FA, Laszlo F. Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 352: 257-261, 1998.
43. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol Gastrointest Liver Physiol 258: G527-G534, 1990.
44. Wallon C, Yang PC, Keita AV, Ericson AC, McKay DM, Sherman PM, Perdue MH, Soderholm JD. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. Gut 57: 50-58, 2008.
45. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166: 409-419, 2005.
46. Ward SM, Bayguinov OP, Lee HK, Sanders KM. Excitatory and inhibitory actions of vasopressin on colonic excitation-contraction coupling in dogs. Gastroenterology 113: 1233-1245, 1997.
47. Weber CR, Turner JR. Inflammatory bowel disease: is it really just another break in the wall? Gut 56: 6-8, 2007.
48. Yamaguchi Y, Yamada K, Suzuki T, Wu YP, Kita K, Takahashi S, Ichinose M, Suzuki N. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 287: E970-E976, 2004.